CNS drugs
Total Trials
11
As Lead Sponsor
3
As Collaborator
8
Total Enrollment
8,004,136
NCT00774917
Numen Stent Assessment Using OCT Technique in a Single Center Study
Phase: Phase 2/3
Role: Collaborator
Start: Oct 31, 2008
Completion: Mar 31, 2010
NCT06700941
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
Phase: N/A
Start: Jan 1, 2012
Completion: Dec 31, 2020
NCT03557853
Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab
Role: Lead Sponsor
Start: Jun 30, 2016
Completion: Jun 30, 2021
NCT04253119
ART First-line Treatment Durability in Russia
Start: Nov 26, 2019
Completion: Jun 30, 2022
NCT04762069
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Phase: Phase 2
Start: May 18, 2021
Completion: Mar 31, 2026
NCT05322083
HIV A6 Genome In ART Unsuccessful Patients On DOR
Start: May 31, 2022
Completion: Jan 31, 2024
NCT05721092
Assessment of Knowledge on Pneumococcal Vaccination Among Diabetologists in India
Start: Feb 20, 2023
Completion: Mar 22, 2024
NCT06995157
Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination
Start: Sep 1, 2023
Completion: Apr 1, 2026
NCT06588257
Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study
Phase: Phase 4
Start: Oct 9, 2024
Completion: Apr 9, 2026
NCT06675721
A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil
Start: Dec 31, 2024
Completion: Dec 31, 2025
NCT06951399
Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer
Start: Sep 1, 2025
Completion: Apr 30, 2028
Loading map...